Literature DB >> 11053083

Efficacy and toxicity of old and new disease modifying antirheumatic drugs.

P Tugwell1, V Welch, M Suarez-Almazor, B Shea, G Wells.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11053083      PMCID： PMC1766628          DOI： 10.1136/ard.59.suppl_1.i32

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  New classification of antirheumatic drugs. The evolution of a concept.

Authors:  J P Edmonds; D L Scott; D E Furst; H E Paulus
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

2.  Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials.

Authors:  D T Felson; J J Anderson; R F Meenan
Journal:  Arthritis Rheum       Date:  1992-10

3.  A double-blind controlled study comparing sulphasalazine with placebo in rheumatoid factor (RF)-negative rheumatoid arthritis.

Authors:  M Farr; L Waterhouse; A E Johnson; G D Kitas; R W Jubb; P A Bacon
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

4.  Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.

Authors:  T Pullar; J A Hunter; H A Capell
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

5.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

6.  A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis.

Authors:  H J Williams; J R Ward; S L Dahl; D O Clegg; R F Willkens; T Oglesby; M H Weisman; S Schlegel; R M Michaels; M E Luggen
Journal:  Arthritis Rheum       Date:  1988-06

7.  Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study.

Authors:  P Hannonen; T Möttönen; M Hakola; M Oka
Journal:  Arthritis Rheum       Date:  1993-11

Review 8.  Combination therapy in rheumatoid arthritis: updated systematic review.

Authors:  A C Verhoeven; M Boers; P Tugwell
Journal:  Br J Rheumatol       Date:  1998-06
  8 in total
  2 in total

Review 1.  Genetic markers of treatment response in rheumatoid arthritis.

Authors:  Joanna Wesoly; Judith A M Wessels; Henk-Jan Guchelaar; Tom W J Huizinga
Journal:  Curr Rheumatol Rep       Date:  2006-10       Impact factor: 4.592

Review 2.  Immunology proves a great success for treating systemic autoimmune diseases - a perspective on immunopharmacology: IUPHAR Review 23.

Authors:  Masaru Ishii
Journal:  Br J Pharmacol       Date:  2017-04-24       Impact factor: 8.739
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.